4//SEC Filing
Brinkley David L 4
Accession 0001179110-13-008498
CIK 0001080014other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 7:07 PM ET
Size
8.5 KB
Accession
0001179110-13-008498
Insider Transaction Report
Form 4
THERAVANCE INCTHRX
Brinkley David L
Head of Business Dev.
Transactions
- Exercise/Conversion
Common Stock
2013-05-13$34.00/sh+16,129$548,386→ 71,129 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-05-13−16,129→ 0 totalExercise: $34.00Exp: 2017-02-13→ Common Stock (16,129 underlying) - Sale
Common Stock
2013-05-13$40.33/sh−16,129$650,483→ 55,000 total
Footnotes (3)
- [F1]DISPOSITIONS MADE PURSUANT TO A PLAN INTENDED TO COMPLY WITH RULE 10b5-1(c).
- [F2]This transaction was executed in multiple trades at prices ranging from $40.06 to $40.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Immediately exercisable.
Documents
Issuer
THERAVANCE INC
CIK 0001080014
Entity typeother
Related Parties
1- filerCIK 0001302445
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 7:07 PM ET
- Size
- 8.5 KB